Gene Expression of Tendon Markers in Mesenchymal Stromal Cells Derived from Different Sources

Overview

Journal BMC Res Notes

Publisher Biomed Central

Specialties Biology
General Medicine

Date 2014 Nov 22

PMID 25412928

Citations 20

Authors

Janina Burk

Claudia Gittel

Sandra Heller

Bastian Pfeiffer

Felicitas Paebst

Annette B Ahrberg

Walter Brehm

Affiliations

Soon will be listed here.

Abstract

Background: Multipotent mesenchymal stromal cells (MSC) can be recovered from a variety of tissues in the body. Yet, their functional properties were shown to vary depending on tissue origin. While MSC have emerged as a favoured cell type for tendon regenerative therapies, very little is known about the influence of the MSC source on their properties relevant to tendon regeneration.The aim of this study was to assess and compare the expression of tendon extracellular matrix proteins and tendon differentiation markers in MSC derived from different sources as well as in native tendon tissue. MSC isolated from equine bone marrow, adipose tissue, umbilical cord tissue, umbilical cord blood and tendon tissue were characterized and then subjected to mRNA analysis by real-time polymerase chain reaction.

Results: MSC derived from adipose tissue displayed the highest expression of collagen 1A2, collagen 3A1 and decorin compared to MSC from all other sources and native tendon tissue (p < 0.01). Tenascin-C and scleraxis expressions were highest in MSC derived from cord blood compared to MSC derived from other sources, though both tenascin-C and scleraxis were expressed at significantly lower levels in all MSC compared to native tendon tissue (p < 0.01).

Conclusions: These findings demonstrate that the MSC source impacts the cell properties relevant to tendon regeneration. Adipose derived MSC might be superior regarding their potential to positively influence tendon matrix reorganization.

Citing Articles

Equine Musculoskeletal Pathologies: Clinical Approaches and Therapeutical Perspectives-A Review.

Reis I, Lopes B, Sousa P, Sousa A, Caseiro A, Mendonca C Vet Sci. 2024; 11(5).

PMID: 38787162 PMC: 11126110. DOI: 10.3390/vetsci11050190.

Curcumin Improves Functional Recovery of Ruptured Tendon by Promoting Tenogenesis via PI3K/Akt Signaling.

Zhang Z, Zhang Y, Wang H, Li B, Cao R, Li Y Stem Cells Transl Med. 2024; 13(5):477-489.

PMID: 38387017 PMC: 11092270. DOI: 10.1093/stcltm/szae007.

The Functions and Mechanisms of Tendon Stem/Progenitor Cells in Tendon Healing.

Lu J, Chen H, Lyu K, Jiang L, Chen Y, Long L Stem Cells Int. 2023; 2023:1258024.

PMID: 37731626 PMC: 10509002. DOI: 10.1155/2023/1258024.

Degenerative tendon matrix induces tenogenic differentiation of mesenchymal stem cells.

Hwang J, Lee S, Jo C J Exp Orthop. 2023; 10(1):15.

PMID: 36786947 PMC: 9928997. DOI: 10.1186/s40634-023-00581-4.

Optimizing Tenogenic Differentiation of Equine Adipose-Derived Mesenchymal Stem Cells (eq-ASC) Using TGFB3 Along with BMP Antagonists.

Shojaee A, Ejeian F, Parham A, Nasr Esfahani M Cell J. 2022; 24(7):370-379.

PMID: 36043405 PMC: 9428478. DOI: 10.22074/cellj.2022.7892.

References

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

Heckman D, Gluck G, Parekh S . Tendon disorders of the foot and ankle, part 2: achilles tendon disorders. Am J Sports Med. 2009; 37(6):1223-34. DOI: 10.1177/0363546509335947. View

Espira L, Lamoureux L, Jones S, Gerard R, Dixon I, Czubryt M . The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis. J Mol Cell Cardiol. 2009; 47(2):188-95. DOI: 10.1016/j.yjmcc.2009.03.024. View

Altman G, Horan R, Martin I, Farhadi J, Stark P, Volloch V . Cell differentiation by mechanical stress. FASEB J. 2002; 16(2):270-2. DOI: 10.1096/fj.01-0656fje. View

Schnabel L, Lynch M, van der Meulen M, Yeager A, Kornatowski M, Nixon A . Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res. 2009; 27(10):1392-8. DOI: 10.1002/jor.20887. View

Young R, Butler D, Weber W, Caplan A, Gordon S, Fink D . Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res. 1998; 16(4):406-13. DOI: 10.1002/jor.1100160403. View

Taylor S, Vaughan-Thomas A, Clements D, Pinchbeck G, Macrory L, Smith R . Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems. BMC Musculoskelet Disord. 2009; 10:27. PMC: 2651848. DOI: 10.1186/1471-2474-10-27. View

Riley G . Tendinopathy--from basic science to treatment. Nat Clin Pract Rheumatol. 2008; 4(2):82-9. DOI: 10.1038/ncprheum0700. View

Crovace A, Lacitignola L, Rossi G, Francioso E . Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int. 2010; 2010:250978. PMC: 2859019. DOI: 10.4061/2010/250978. View

10.

Kuo C, Tuan R . Mechanoactive tenogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A. 2008; 14(10):1615-27. DOI: 10.1089/ten.tea.2006.0415. View

11.

Brellier F, Tucker R, Chiquet-Ehrismann R . Tenascins and their implications in diseases and tissue mechanics. Scand J Med Sci Sports. 2009; 19(4):511-9. DOI: 10.1111/j.1600-0838.2009.00916.x. View

12.

Vidal M, Walker N, Napoli E, Borjesson D . Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue. Stem Cells Dev. 2011; 21(2):273-83. DOI: 10.1089/scd.2010.0589. View

13.

Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins R, Kobayashi N . Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 2010; 19(6):667-79. PMC: 2957533. DOI: 10.3727/096368910X508762. View

14.

Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C . Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources. Vet J. 2012; 195(1):98-106. DOI: 10.1016/j.tvjl.2012.06.004. View

15.

Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I . Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 2006; 327(3):449-62. DOI: 10.1007/s00441-006-0308-z. View

16.

Schweitzer R, Chyung J, Murtaugh L, Brent A, Rosen V, Olson E . Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development. 2001; 128(19):3855-66. DOI: 10.1242/dev.128.19.3855. View

17.

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

18.

Scott A, Huisman E, Khan K . Conservative treatment of chronic Achilles tendinopathy. CMAJ. 2011; 183(10):1159-65. PMC: 3134723. DOI: 10.1503/cmaj.101680. View

19.

Thorpe C, Clegg P, Birch H . A review of tendon injury: why is the equine superficial digital flexor tendon most at risk?. Equine Vet J. 2010; 42(2):174-80. DOI: 10.2746/042516409X480395. View

20.

Godwin E, Young N, Dudhia J, Beamish I, Smith R . Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J. 2011; 44(1):25-32. DOI: 10.1111/j.2042-3306.2011.00363.x. View